SIMORQ
Timeline
8 events since 2022Board
Filings
Financial
Establishments
20222023202420252026
Deadline for the 2026 accounts: 31-07-2027
2026
Annual accounts 2025 filed PDFmicro format · 60 days before the deadline
2025
Weakest financial year net -€2,272 The net result drops to -€2,272, the lowest from 2023 to 2025.
Registered in the Peppol Directory Reachable for e-invoices through 0208:0786684846
Annual accounts 2024 filed PDFmicro format · 75 days before the deadline
2024
Appointments: AKCHICH Mohammed (director) and CANINI Sergio (managing director)“De groothandel, de aan en verkoop, de bereiding van alle soorten scheikundige, farmaceutische…” (deed in Dutch) · General meeting of 21-10-20246 points ▸
- General meeting, 21-10-2024
- Purpose change, “De groothandel, de aan en verkoop, de bereiding van alle soorten scheikundige, farmaceutische, para-farmaceutische, fytofarmaceutische producten, veeartsenij-…” (deed in Dutch)
- Director appointment, AKCHICH Mohammed (director (not named in the articles))
- Board composition, CANINI Sergio (director)
- Board composition, AKCHICH Mohammed (director)
- Director appointment, CANINI Sergio (managing director)
- The deed holds 3 more points.
Annual accounts 2023 filed PDFmicro format · 79 days before the deadline
2022
IncorporationFounder: CANINI Sergio · 100 shares · Appointment: CANINI Sergio (director) · published on 02-06-20224 points ▸
- Founder, CANINI Sergio
- 100 shares
- Registered office clause, Molenstraat 82, 3600 Genk
- Director appointment, CANINI Sergio
- The deed holds 1 more point.
First establishment BIOMEDIC PHARMA, Molenstraat 82, Genk
Financial milestones sit on the financial year-end date, not the filing date.
Sources: Publications in the Belgian Official GazetteFilings with the National Bank